Endocrine Testing Market Size, Share & Trends Report

Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (TSH, hCG Hormone), By End-use (Hospitals, Commercial Laboratories), By Technology (Immunoassay, Clinical Chemistry), And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-862-6
  • Number of Report Pages: 180
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2023
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Market Segmentation

  • Endocrine Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Estradiol (E2) Test
    • Follicle Stimulating Hormone (FSH) Test
    • Human Chorionic Gonadotropin (hCG) Hormone Test
    • Luteinizing Hormone (LH) Test
    • Dehydroepiandrosterone Sulfate (DHEAS) Test
    • Progesterone Test
    • Testosterone Test
    • Thyroid Stimulating Hormone (TSH) Test
    • Prolactin Test
    • Cortisol Test
    • Insulin Test
    • Others
  • Endocrine Testing Technology Outlook (Revenue, USD Million, 2018 - 2030)
    • Tandem Mass Spectrometry
    • Immunoassay
    • Monoclonal & Polyclonal Antibody Technologies
    • Sensor Technology
    • Clinical Chemistry
    • Others
  • Endocrine Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Commercial Laboratories
    • Ambulatory Care Centers
    • Others
  • Endocrine Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Test Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Estradiol (E2) Test
        • Follicle Stimulating Hormone (FSH) Test
        • Human Chorionic Gonadotropin (hCG) Hormone Test
        • Luteinizing Hormone (LH) Test
        • Dehydroepiandrosterone Sulfate (DHEAS) Test
        • Progesterone Test
        • Testosterone Test
        • Thyroid Stimulating Hormone (TSH) Test
        • Prolactin Test
        • Cortisol Test
        • Insulin Test
        • Others
      • North America Technology Outlook (Revenue in USD Million, 2018 - 2030)
        • Tandem Mass Spectrometry
        • Immunoassay
        • Monoclonal & Polyclonal Antibody Technologies
        • Sensor Technology
        • Clinical Chemistry
        • Others
      • North America End-use Outlook (Revenue in USD Million, 2018 - 2030)
        • Hospitals
        • Commercial Laboratories
        • Ambulatory Care Centers
        • Others
      • U.S.
        • U.S. Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • U.S. Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • U.S. End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Canada
        • Canada Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Canada Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Canada End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
    • Europe
      • Europe Test Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Estradiol (E2) Test
        • Follicle Stimulating Hormone (FSH) Test
        • Human Chorionic Gonadotropin (hCG) Hormone Test
        • Luteinizing Hormone (LH) Test
        • Dehydroepiandrosterone Sulfate (DHEAS) Test
        • Progesterone Test
        • Testosterone Test
        • Thyroid Stimulating Hormone (TSH) Test
        • Prolactin Test
        • Cortisol Test
        • Insulin Test
        • Others
      • Europe Technology Outlook (Revenue in USD Million, 2018 - 2030)
        • Tandem Mass Spectrometry
        • Immunoassay
        • Monoclonal & Polyclonal Antibody Technologies
        • Sensor Technology
        • Clinical Chemistry
        • Others
      • Europe End-use Outlook (Revenue in USD Million, 2018 - 2030)
        • Hospitals
        • Commercial Laboratories
        • Ambulatory Care Centers
        • Others
      • U.K.
        • U.K. Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • U.K. Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • U.K.  End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Germany
        • Germany Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Germany Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Germany End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • France
        • France Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • France Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • France End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Italy
        • Italy Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Italy Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Italy End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Spain
        • Spain Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Spain Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Spain End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Denmark
        • Denmark Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Denmark Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Denmark End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Sweden
        • Sweden Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Sweden Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Sweden End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Norway
        • Norway Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Norway Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Norway End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
    • Asia Pacific
      • Asia Pacific Test Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Estradiol (E2) Test
        • Follicle Stimulating Hormone (FSH) Test
        • Human Chorionic Gonadotropin (hCG) Hormone Test
        • Luteinizing Hormone (LH) Test
        • Dehydroepiandrosterone Sulfate (DHEAS) Test
        • Progesterone Test
        • Testosterone Test
        • Thyroid Stimulating Hormone (TSH) Test
        • Prolactin Test
        • Cortisol Test
        • Insulin Test
        • Others
      • Asia Pacific Technology Outlook (Revenue in USD Million, 2018 - 2030)
        • Tandem Mass Spectrometry
        • Immunoassay
        • Monoclonal & Polyclonal Antibody Technologies
        • Sensor Technology
        • Clinical Chemistry
        • Others
      • Asia Pacific End-use Outlook (Revenue in USD Million, 2018 - 2030)
        • Hospitals
        • Commercial Laboratories
        • Ambulatory Care Centers
        • Others
      • China
        • China Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • China Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • China End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Japan
        • Japan Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Japan Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Japan End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • India
        • India Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • India Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • India End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Australia
        • Australia Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Australia Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Australia End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Thailand
        • Thailand Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Thailand Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Thailand End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • South Korea
        • South Korea Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • South Korea Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • South Korea End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
    • Latin America
      • Latin America Test Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Estradiol (E2) Test
        • Follicle Stimulating Hormone (FSH) Test
        • Human Chorionic Gonadotropin (hCG) Hormone Test
        • Luteinizing Hormone (LH) Test
        • Dehydroepiandrosterone Sulfate (DHEAS) Test
        • Progesterone Test
        • Testosterone Test
        • Thyroid Stimulating Hormone (TSH) Test
        • Prolactin Test
        • Cortisol Test
        • Insulin Test
        • Others
      • Latin America Technology Outlook (Revenue in USD Million, 2018 - 2030)
        • Tandem Mass Spectrometry
        • Immunoassay
        • Monoclonal & Polyclonal Antibody Technologies
        • Sensor Technology
        • Clinical Chemistry
        • Others
      • Latin America End-use Outlook (Revenue in USD Million, 2018 - 2030)
        • Hospitals
        • Commercial Laboratories
        • Ambulatory Care Centers
        • Others
      • Brazil
        • Brazil Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Brazil Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Brazil End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Mexico
        • Mexico Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Mexico Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Mexico End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Argentina
        • Argentina Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Argentina Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Argentina End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
    • Middle East & Africa
      • Middle East & Africa Test Type Outlook (Revenue in USD Million, 2018 - 2030)
        • Estradiol (E2) Test
        • Follicle Stimulating Hormone (FSH) Test
        • Human Chorionic Gonadotropin (hCG) Hormone Test
        • Luteinizing Hormone (LH) Test
        • Dehydroepiandrosterone Sulfate (DHEAS) Test
        • Progesterone Test
        • Testosterone Test
        • Thyroid Stimulating Hormone (TSH) Test
        • Prolactin Test
        • Cortisol Test
        • Insulin Test
        • Others
      • Middle East & Africa Technology Outlook (Revenue in USD Million, 2018 - 2030)
        • Tandem Mass Spectrometry
        • Immunoassay
        • Monoclonal & Polyclonal Antibody Technologies
        • Sensor Technology
        • Clinical Chemistry
        • Others
      • Middle East & Africa End-use Outlook (Revenue in USD Million, 2018 - 2030)
        • Hospitals
        • Commercial Laboratories
        • Ambulatory Care Centers
        • Others
      • South Africa
        • South Africa Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • South Africa Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • South Africa End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Saudi Arabia
        • Saudi Arabia Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Saudi Arabia Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Saudi Arabia End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • UAE
        • UAE Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • UAE Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • UAE End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others
      • Kuwait
        • Kuwait Test Type Outlook (Revenue in USD Million, 2018 - 2030)
          • Estradiol (E2) Test
          • Follicle Stimulating Hormone (FSH) Test
          • Human Chorionic Gonadotropin (hCG) Hormone Test
          • Luteinizing Hormone (LH) Test
          • Dehydroepiandrosterone Sulfate (DHEAS) Test
          • Progesterone Test
          • Testosterone Test
          • Thyroid Stimulating Hormone (TSH) Test
          • Prolactin Test
          • Cortisol Test
          • Insulin Test
          • Others
        • Kuwait Technology Outlook (Revenue in USD Million, 2018 - 2030)
          • Tandem Mass Spectrometry
          • Immunoassay
          • Monoclonal & Polyclonal Antibody Technologies
          • Sensor Technology
          • Clinical Chemistry
          • Others
        • Kuwait End-use Outlook (Revenue in USD Million, 2018 - 2030)
          • Hospitals
          • Commercial Laboratories
          • Ambulatory Care Centers
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon